Full name
NEPHROLAB PLUS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
NEPHROLAB PLUS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. ŻWIRKI I WIGURY 101, 02-089 WARSZAWA
TAX ID7010896355
Rate company:
NEPHROLAB PLUS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7010896355
KRS0000762320
Share capital5,000.00 zł
address
UL. ŻWIRKI I WIGURY 101, 02-089 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7010896355
REGON
382018768
KRS
0000762320
Legal form
limited liability company
Register Address
UL. ŻWIRKI I WIGURY 101, 02-089 WARSZAWA
Date of registration in KRS
2018-12-12
Date of commencement of economic activity
2018-12-12
Act signature
RDF/597832/24/711
Pkd codes
72.11.Z - Research and experimental development on biotechnology
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
86.90.E - Other human health activities notelsewhere classified
EU grants
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets  | 0,4 | 0 | 0,2 | 441 |
Profit (loss) on sale | -30,1 | -8,1 | -6,3 | 22,6 |
Gross profit (loss) | -30,1 | -8,1 | -6,3 | 22,6 |
EBITDA | ||||
Net profit (loss) | -30,1 | -8,1 | -6,3 | 22,6 |
Cash | 0,4 | 0 | 0,2 | 441 |
Liabilities and provisions for liabilities | 28,8 | 36,7 | 43,1 | 17,7 |
Short time liabilities | 28,8 | 36,7 | 43,1 | 17,7 |
Other operating costs | ||||
Working assets | 0,4 | 0 | 0,2 | 441 |
Equity capital | -28,5 | -36,6 | -42,9 | -17,2 |
Other income costs | ||||
Operating profit (EBIT) | ||||
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 105,7 | 22,2 | 14,7 | -7,5 |
Equity capital to total assets | -7889,5 | -93 821,2 | -20 344,3 | 73 476,9 |
Current financial liquidity indicator | 0.012516383081674576 | 0.0010647218441590667 | 0.004891341086477041 | 0 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
BIOCELTIX SPÓŁKA AKCYJNA
WROCŁAW